We are excited to announce that Centauri Therapeutics Limited, a UK-based biotechnology innovator, has successfully raised £4,300,000 in new funding designed to accelerate its breakthrough research in combating life-threatening diseases. Centauri Therapeutics is at the forefront of modern drug discovery, leveraging its exemplary Alphamer technology—a cutting-edge approach based on programmable immunity. This innovative methodology involves chemically synthesised molecules that redirect naturally occurring antibodies to specific pathogens, thereby triggering a swift and targeted antibacterial immune response. By incorporating two distinct molecular components, where one end binds to a cell surface target on the pathogen using an aptamer and the other presents epitopes to engage circulating antibodies, Alphamers hold the potential to transform how bacterial infections are treated. With this infusion of capital, the company is poised to deepen its research and development efforts, further hone its platform chemistry, and expand its pipeline of promising leads. The secured funding will empower Centauri Therapeutics to bolster its preclinical programs and refine the robust intellectual property portfolio underpinning its innovative technology. This financial milestone not only underscores the confidence of investors in Centauri’s scientific vision and proprietary advancements but also sets the stage for accelerated progress towards new therapeutic solutions. As the company continues to build upon a strong foundation of granted patents and ongoing applications, it remains committed to addressing critical unmet medical needs and improving patient outcomes. This announcement marks an exciting chapter for Centauri Therapeutics as it leverages its unique technology to redefine antibacterial therapies and pave the way for a new era in biotechnology.
Centauri Therapeutics Secures £4.3M to Propel Breakthrough Programmable Immunity and Alphamer Technology
Get the full Centauri Therapeutics Limited company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
HR Path
HR Path, an expert, and a major player in Human Resources, helps companies for who the human experience is essential to their digital transformation. Advise, Implement & Outsource are the 3 business lines of HR Path which contribute our customers corporate HR performance. Created in 2001 in Paris, France and with its 2,600 talents, HR Path advises, integrates, and operates for more than 3,000 clients in 29 countries. Its turnover will amount to €360 million euros in March 2026.
$30.0M Series b
today
Ledger
At Ledger, we’re proud to be the global platform for digital assets and Web3, with over 20% of the world’s crypto assets secured through our Ledger devices. With our headquarters in Paris, and offices in Vierzon, Grenoble, Montpellier, London, Portland, Geneva, Zurich and Central Singapore, we have a team of around 600 professionals developing a variety of products and services to enable individuals and companies to securely buy, store, swap, grow and manage crypto assets – including the Ledger hardware wallets line with more than 7.5 millions units already sold in 200 countries. We’re a team of experts pushing the limits of what’s possible, united by our common goal to unlock true freedom through digital ownership, making technology accessible for all. We believe in a world where users, creators and enterprises manage their value with ownership and freedom. Our curiosity drives us to innovate, empowering individuals on a global scale. We believe change is constant and our team moves forward as one, with a culture of problem-solving where every employee is empowered and supported to challenge tradition and create solutions. Our mission is simple: to make self-custody accessible and give people the keys to their own financial futures. If you want to make a true impact, we want you to join us at Ledger.
$50.0M Unknown
today
H Company
Leading edge research, proprietary models and agents, and a forward-deployed implementation approach for tangible ROI
$12.0M Series a
today
Prelude
Organizations of all sizes depend on Prelude to know with certainty that their defenses will protect them against the latest threats. Prelude's security control validation platform provides the essential and continuous visibility into the state of your security controls, their configuration, and how they map against the latest threats. With actionable insights into how to maximize the tools you already have, Prelude ensures you get the most out of your security controls, align to compliance, and stay protected. Learn more: preludesecurity.com
$18.7M Series a
today
Meta Fashion
Meta Fashion is a phygital fashion platform that converts fashion discovered inside games into real-world purchases. We’ve scaled 2.5M+ virtual fashion sales, created 10+ all-time bestsellers, and have been directly recognized by Roblox through creator and platform programs. Our flagship product, Glam Girls, is a fashion-first Roblox experience that owns discovery and distribution. It’s live in beta with 80K+ paid, organic users. We identify winning digital fashion signals, convert only proven hits into physical products via India’s manufacturing network, and sell globally through in-game checkout and D2C. Meta Fashion operates at the intersection of gaming, fashion, and next-generation commerce.
$400.0K Pre-seed
today